DAFTAR PUSTAKA

1. Djojodibroto RD. (2009). Respirologi (Respiratory Medicine). Jakarta:

EGC.
2. Maranatha, Daniel. (2010). Penyakit Paru Obstruksi Kronis. Buku Ajar Ilmu
Paru. Surabaya: Departemen Ilmu Penyakit Paru FK Unair.
3. Global Initiative for Chronic Obstructive Lung Disease . Global strategy for
the diagnosis, management and prevention of chronic obstructive pulmonary
disease. Updated 2103. Global Initiative for Chronic Obstructive Lung
Disease

website.

http://www.goldcopd.

org/uploads/users/files/

GOLD_Report_2013_Feb20.pdf . Accessed August 31, 2016 .

4. ReillyJJ., Silverman EK., Shapiro SD. (2015). Chronic Obstructive
Pulmonary Disease. Dalam: Kasper, D.L., Hauser, S.L., Jameson, J.L.,
Fauci, A.S., Longo, D.L., dan Loscalzo J. (eds) Harrisons Principle of
Internal Medicine (Edisi 19). New York: McGRaw Hill.
5. Alwi I, Salim S, Hidayat R, Jurniawan J, dan Tahaparty DL (editors) .
(2015). Penatalaksanaan di Bidang Ilmu Penyakit Dalam Panduan Praktik
Klinis. Jakarta: InternaPulishing.
6. MacNes W., (2011). Pathology and Pathogenesis. Dalam: Currie GP
(editor) Clinical Respiratory Medicine Fourth Edition. London: Blackwell
Publishing.
7. Hurst JR dan Wedzicha JA. (2011). Management of Exacerbations in
Chronic Obstructive Pumonary Disease. . Dalam: Currie GP (editor)
Clinical Respiratory Medicine Fourth Edition. London: Blackwell
Publishing.
8. Wardhani DP dan Uyainah A. (2014). Penyakit Paru Obstruktif Kronis.
Dalam: Tanto, C., Liwang, F., Hanifati, S., dan Pradipta, E.A. (eds) Kapita
Selekta Kedokteran Essensial of Medicine (Edisi 4). Jakarta: Media
Aesculapius.
9. GOLD Report. Global Strategy for the diagnosis, management, and
prevention of COPD. Update 2013 Available from www.goldcopd.org (cited
31 August 2016).

20

21

10. Devereux GS. (2011). Definition, Epidemiology and Risk Factors. Dalam:
Currie GP (editor) ABC of COPD Second Edition. London: Blackwell
Publishing.
11. Sethi S and Veramamachaeneni SB,. Pathogenesis of bacterial exacerbation
of COPD. J COPD. 2006; 3:109-16.

1. Brusasco V . Reducing cholinergic constriction: the major reversible

mechanism in COPD . Eur Respir Rev . 2006 ; 15 ( 99 ): 32 - 36 .

22

2. Cooper CB . Airfl ow obstruction and exercise . Respir Med . 2009 ;

103 ( 3 ): 325 - 334 .
3. Public Health Agency of Canada. Chronic obstructive pulmonary
disease (COPD). Public Health Agency of Canada website . http://
www.phac-aspc.gc.ca/cd-mc/crd-mrc/copd-mpoc-eng.php . Accessed
June 28, 2012 .
4. Centers for Disease Control and Prevention; National Center for
Health Statistics . Deaths: fi nal data for 2009 . Natl Vital Stat Rep .
2012 ; 60 ( 3 ): 1 - 117 .
5. Centers for Disease Control and Prevention; National Center for
Health Statistics . National Health Interview Survey Raw Data,
6. 1999-2011. Analysis performed by the American Lung Association
Research and Health Education Division using SPSS and SUDAAN
soft ware . Atlanta, GA : Centers for Disease Control and Prevention ;
2011 .

Globol strotegy for the diognosis, monogement, ond prevention of chronic obstructive pulmonory
diseose. Globol initiotive for Chronic Obsiructive Lung Diseose. 2006.